MCA logo



Sotrovimab: an introduction of use in Singapore


As the COVID-19 pandemic enters into its 18-month mark, the global race for novel therapeutics blazes on, with international guidelines being updated to include new therapeutic agents by the flurried month.

Relative to other countries, the face of the pandemic locally . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Conjunctivitis asia singapore
Singapore’s Conjunctivitis Cases Rocket by 75%

A massive upsurge in conjunctivitis cases has been recorded in Singapore this year. Compared to 2022, daily recorded cases between January and July 2023 witnessed an alarming 75% rise. Polyclinics noted an average of 63 acute conjunctivitis cases daily, a significant hike from the 36 daily cases reported in the same period last year.

Read More »